Antitumor compounds from  sp. KML-2, isolated from Khewra salt mines, Pakistan by unknown




from Streptomyces sp. KML-2, isolated 
from Khewra salt mines, Pakistan
Usman Aftab1,2*, David L. Zechel2 and Imran Sajid1
Abstract 
Background: Actinomycetes are gram positive bacteria with high G + C content in their DNA and are capable of 
producing variety of secondary metabolites. Many of these metabolites possess different biological activities and 
have the potential to be developed as therapeutic agents. The aim of the present study was to screen actinomy-
cetes inhabiting halophilic environment such as Khewra salt mines present in Pakistan for cytotoxic and antitumor 
compounds.
Results: An actiomycetes strain designated as Streptomyces sp. KML-2 was isolated from a saline soil of Khewra salt 
mines, Pakistan. The strain Streptomyces sp. KML-2 showed 84 % cytotoxic activity against larvae of Artemia salina. In 
the screening phase, the strain exhibited significant antitumor activity with IC50 values of 12, 48 and 56 µg/ml against 
Hela, MDBK and Vero cell lines, respectively. After that extract from 20 l fermentation was used to purify secondary 
metabolites by several chromatographic techniques. Structure elucidation of isolated compounds revealed that it 
is highly stable producer of Chromomycin SA (1) and 1-(1H-indol-3-yl)-propane-1,2,3-triol (2). Both of the isolated 
compounds showed significant antitumor activity against Hela and MCF-7 cancer cell lines (IC50 values 8.9 and 7.8 µg/
ml against Hela; 12.6 and 0.97 µg/ml against MCF-7, respectively). The 16S rRNA gene sequence (1437 bp) of the strain 
confirm its identity (99 %) with Streptomyces griseus.
Conclusions: From this research work we were successful in isolating two potent antitumor compounds, Chromo-
mycin SA and 1-(1H-indol-3-yl)-propane-1,2,3-triol from Streptomyces KML-2 strain, isolated from Khewra salt mine. As 
such this is the second report which confirms that S. griseus can produce Chromomycin SA without introducing any 
mutagenesis in its biosynthesizing gene cluster and isolated indole derivative is being reported first time from any 
member of actinomycetes group with having novel antitumor activity against Hela and MCF-7 cells.
Nucleotide sequences: Nucleotide sequence data reported are available in the GenBank database under the acces-
sion number: GenBank KJ009562.
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Background
Nature is an attractive source of new therapeutic com-
pounds, as it represents a pool of secondary metabolites 
with tremendous chemical diversity. Currently about 
60 % of the approved therapeutic drugs are derived from 
natural sources. These sources include various animals, 
plants, marine-organisms, and microorganisms [1, 2]. 
Among the different microbial sources, actinomycetes 
specifically are famous as producers of great number of 
unique and chemically diverse bioactive compounds. 
Actinomycetes are filamentous, gram-positive, spore 
forming bacteria [3]. Members of the class actinomycetes 
are reported for the production of about 10,000 bioactive 
compounds among the total 23,000 bioactive secondary 
metabolites produced by microorganisms, representing 
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43 % of all bioactive microbial metabolites that have been 
discovered [4].
Actinomycetes are also known as a rich source of potent 
antitumor compounds. Regardless of the presence of 
several therapeutic methods for the cancer treatment, 
cancer is still a major public health threat [5]. Chemo-
therapy is one of the effective treatments for controlling 
cancer, but this approach needs a continuous supply of 
new antitumor compounds. Fortunately, one of the fam-
ily members of actinomycetes known as Streptomyces 
helps us by providing promising antitumor compounds, 
which are unmatched and unrivaled in terms of treatment 
of cancer. The famous antitumor compounds produced 
by Streptomyces species and are being used in human 
chemotherapy includes actinomycin, mitomycin, anthra-
cycline, bleomycin, aureolic acid families, pentostatin and 
resistomycin [6, 7]. Several studies confirm that Strepto-
myces are able to produce different antitumor compounds 
with diverse chemical backbones because they harbor dif-
ferent gene clusters encoding polyketide and nonriboso-
mal peptide synthases [8]. Most of these compounds are 
secreted in the culture media and can be extracted using 
organic solvents [9]. There are many diverse mechanisms 
by which these compounds are able to control different 
tumor cells which includes apoptosis, mitochondrial per-
meabilization, blockage of signal transduction pathways 
by inhibiting key enzymes, cytomorphological changes 
due to disturbance in cellular differentiations, and tumor 
induced angiogenesis [10]. Sometime antitumor com-
pounds isolated from Streptomyces strains act by inter-
calating with duplex DNA, which leads to detrimental 
effects on fast proliferating cells by inhibiting the DNA-
dependent RNA polymerase activities [11].
In order to establish a unique pool of Streptomyces 
strains that can be examined for new anticancer drugs, 
we focused on gathering strains from unique habitats and 
conducting target directed biological screening [12, 13]. 
Among different habitats, normal terrestrial habitat is 
the most explored one, while there are very few studies 
conducted on extreme ecological niches, like forests, salt 
stress areas, hills, desert etc. [14]. Our aim from both of 
these strategies is to attain novelty in biological activities 
and chemical structures.
To this end, the present study reports the isolation of a 
Streptomyces strain, KML-2, from the Khewra salt mines 
in Pakistan. Culture extracts from KML-2 exhibited 
potent cytotoxic activity against Artemia s. larvae and 
antiproliferative activity against three cell lines. These 
activities inspired us to isolate the bioactive molecules 
and determine their structures and bioactivities. Phylo-
genetic analysis was performed by conducting ribotyping 
studies of the strain KML-2.
Results and discussion
Isolation and taxonomic characteristics of Streptomyces sp. 
KML‑2
In order to meet the increasing demand for the treatment 
of human illness, new biologically active metabolites are 
needed. In this battle microorganisms are generally, and 
in particular actinomycetes, are prominent producers of 
chemically diverse compounds with multiple activities. 
However after several decades of extensive screening it 
has become difficult to simultaneously find novel com-
pounds and novel microorganisms. Despite of this fact, 
there are some unique ecological niches in the world 
which are unexplored and could be a source of novelty, 
both for the microorganisms and their compounds. In 
our case we selected a unique and untapped source for 
the isolation of actinomycetes, the Khewra salt mine, 
which is the world’s second largest salt mine, located in 
the province Punjab, Pakistan [15]. Recently few studies 
report the isolation of novel actinomycetes strains from 
salt rich environments [16–18].
Several soil samples were collected from the mine 
and plated on the selective media after making suitable 
dilutions. After incubation actinomycetes strains were 
isolated and purified on GYM agar. The strain KML-2 
exhibited typical Streptomycetes like characteristics 
(Table  1). Individual colonies grew well in an elevated 
manner with red vegetative mycelia and yellow aerial 
mycelia. As depicted in the scanning electron microscope 
image, the spore chains were straight, smooth, thick, and 
branched with very little coiling. The diameters of the 
spores are constant with having connection to substrate 
mycelia (Fig. 1a–d). All of the morphological and surface 
parameters observed under scanning electron micro-
scope are in close similarity with family known as Strep-
tomycetaceae and the genus Streptomyces.  
The comparison of biochemical, physiological and 
microscopic characteristics (Table 1) with those of known 
actinomycetes species mentioned in Bergey’s Manual of 
Systematic Bacteriology strongly suggested that the strain 
KML-2 belongs to the genus Streptomyces [19]. It can uti-
lized d-galactose, d-glucose, mannose, glycerol and man-
nitol as a carbon source indicating its ability to grow on 
variety of sugars. The strain tested negative in biochemi-
cal tests like hemolysis and melanin production. Out 
of several organic acids tested for utilization, the strain 
KML-2 utilized only potassium gluconate and trisodium 
citrate (Table 1).
Several molecular techniques are being used in the 
research for investigating the evolutionary relation-
ship among isolated microorganisms. By the help of 
these kinds of molecular techniques we can easily verify 
the hypothesis generated from other characterization 
Page 3 of 10Aftab et al. Biol Res  (2015) 48:58 
methods like physiological and biochemical tests [20]. 
Among all the techniques ribotyping is very commonly 
used one, in which 16S rRNA gene sequence data of the 
isolated strain is compared with the sequence data pre-
sent in the Genbank database. In our case we are able 
to sequence total nucleotide of 1437  bp (Accession No: 
KJ009562) of the 16S rRNA gene of Streptomyces sp. 
KML-2. The BLAST analysis was performed by aligning 
this sequence with the 16S rRNA gene sequences present 
in the Genbank database. Blast results exhibited highest 
similarity (99  % similarity) with the 16S rRNA gene of 
Streptomyces griseus (Fig. 2).
Cytotoxicity and antitumor activity of Streptomyces sp. 
KML‑2
A significant challenge in isolating bioactive compounds 
from microorganisms is having an appropriate and sensi-
tive bioassay to guide the purification process [21]. In our 
case we screened extracts from Streptomyces sp. KML-2 
using several bioassays in order to exploit its full chemi-
cal potential. We started with measuring the cytotoxic 
effects of the crude extract of this strain against the lar-
vae of Artemia s. commonly known as brine shrimp [22]. 
The cytotoxic profile of the crude extract from Strepto-
myces sp. KML-2 showed very promising results. This 
strain produces compounds which have the ability to 
inhibit 84 % of the growth of Atremia s. larvae. The high 
cytotoxic response against Artimia s. suggests that the 
extract of this strain might contain some potent anti-
tumor compounds. We then selected the MTT assay 
to test the antitumor activity of this strain against Hela 
cells (cervical cancer) and two normal cell lines including 
MDBK (cow kidney epithelial cells) and Vero cells (Afri-
can green monkey kidney epithelial cells). We observed 
differential antitumor activity against tested cell lines in 
a dose-dependent manner. The survival rate of Vero and 
MDBK cells is higher compared to Hela cells. IC50 val-
ues for Hela, MDBK and Vero cells were 12.17, 47.88 and 
56.12 µg/ml respectively. Such differential behavior with 
several normal and cancer cell lines including Hela were 
observed for the extracts and pure compounds isolated 
Table 1 Taxonomic characteristics of  the Streptomyces sp. 
KML-2
+, positive; −, negative; ++, strong positive
Observed results
Morphological parameters
 Aerial mycelium Detachable/pale yellow
 Substrate mycelium Abundant/red
 Diffusible pigments Nil
 Fragmentation pattern of substrate mycelium Fair
 Spores Abundant/smooth






 Growth pattern Well growth/partitioned
 Shape/form Circular
 Optical feature Opaque
 Gram stain Positive
 Motility Nil












Utilization of organic acids
 Potassium gluconate +
 Trisodium citrate +
 Sodium malate −
 Sodium lactate −
 Sodium malonate −
 Oxalate −
Fig. 1 a, b Substrate and Aerial mycelia of Streptomyces sp. KML-2; c, d scanning electron microscope images of Streptomyces sp. KML-2
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from different Streptomyces species in several studies 
[23–27]. These data indicate that the MTT assay utilized 
in our study is suitable for screening antitumor agents 
with high cytotoxic activities. No significant antibacterial 
activity was seen when the extracts was screened against 
the general panel of gram positive and gram negative 
bacteria.
Later on after isolation and purification, the anti-
tumor activity of two pure culprit compounds was 
also evaluated by using MTT assay. Initially antitu-
mor potential of the compound 1 and 2 was checked 
against Hela and MCF-7 (breast cancer) cell lines. It 
is observed that both compounds showed significant 
antitumor activity against both cell lines with IC50 
value of 8.9 and 7.8  µg/ml against Hela cells respec-
tively. Activity of compound 1 against MCF-7 is also 
significant with having IC50 value of 12.6  µg/ml, 
but compound 2, which was found novel in terms of 
source and activity after performing structure elucida-
tion experiments, shows marvelous antitumor poten-
tial against MCF-7 cells with having IC50 value of only 
0.97 µg/ml (Fig. 3).
Purification and structure elucidation of the antitumor 
metabolites
The 20 l shaking flasks culture of the isolate Streptomyces 
sp. KLM-2 was extracted using Diaion HP-20 beads and 
1.5  g red color crude extract was obtained. Two differ-
ent compounds were separated by preparative TLC. The 
compound 1 is yellow in color with λmax at 437, 317 and 
280 nm. After that this pure compound was analyzed on 
UPLC/MS system and m/z ratio of 1125.47 [M + H]+ was 
observed in positive ES mode. This value, along with the 
distinct absorbance spectrum is consistent with already 
reported compound named as Chromomycin SA hav-
ing Chemical formula: C54H76O25, Exact mass: 1124.47, 
Molecular weight: 1125.17, Elemental analysis: C, 57.64; 
H, 6.81; O 35.55 (Figs. 4a, 5a). Results of 1H-NMR experi-
ment for this isolated compound confirmed its identity 
as Chromomycin SA (Additional file 1: Table S1). Chro-
momycin SA is a yellow color compound produced by 
Streptomyces griseus, already reported for a potent activ-
ity against Hela cells [23]. Our phylogenetic, morphologi-
cal and physiological analysis also confirm that our strain 
have 99  % similarity with S. griseus. Chromomycin SA 
Fig. 2 Phylogenetic tree of Streptomyces sp. KML-2
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belongs to the class of polyketide compounds known as 
aureolic acids. Aureolic acid family contains potent anti-
tumor compounds which inhibit the replication and tran-
scription process during macromolecules biosynthesis. 
They also interact with the minor groove of DNA in GC-
rich region. This binding is non-intercalative in nature, 
via cross linking of DNA in the presence of Mg2+ [28]. 
Previously Menéndez et  al. [23] reported isolation of 
Chromomycin SA from a S. griseus strain that has been 
genetically altered specifically through the inactiva-
tion of ketoreductase gene (cmmW1). Later on Hu et al. 
[29] reports the isolation of Chromomycin SA without 
introducing any mutation in ketoreductase gene. They 
proposed that Chromomycin SA is byproduct in nature, 
formed during the synthesis of different analogs of Chro-
momycin SA. They have isolated the S. griseus strain 
from saline environment which is also similar in our 
case. So we can hypothesized that might be there is some 
relation between inactivation of ketoreductase gene and 
stress acclimatization. Latest studies have also introduced 
the new term known as ecovars, in which strains of S. 
griseus might be undergoing ecology-specific evolution, 
which results in the genetic variation with the specific 
ecology [30].
Compound 2 with m/z 208 [M + H]+ was purified by 
column chromatography over silica gel with the Metha-
nol: Dichloromethane solvent gradient system and 
Sephadex LH-20 column. After purification 6 mg of pure 
compound was obtained. Structure of this pure com-
pound was determined through Bruker Avance 600 MHz 
NMR spectrometer. After performing several two dimen-
sional NMR experiments compound 2 was identified as 
1-(1H-indol-3-yl) propane- 1, 2, 3-triol (Fig.  4b), one of 
the derivative of indolic compounds (Additional file  1: 
Table S2) with Chemical formula: C11H13NO3, Exact 
mass: 207.09, Molecular weight: 207.23, Elemental analy-
sis: C, 63.76; H, 6.32; N, 6.76; O, 23.16. To the best of our 
knowledge this type of indolic derivative has not been 
reported earlier from Streptomyces source, however one 
study depicted its isolation from clavicipitaceous fungi 
Balansia epichloe (B. epichloë) with high toxicity against 
fertile chicken eggs [31]. Earlier only fungus is reported 
among natural sources for the production of this type 
indolic derivative but now some studies also reports its 
chemical synthesis [32]. Several actinomycetes strains 
were reported for the presence of tryptophan metabolism 
gene clusters, which are responsible for the production 
of different indolic derivatives [33]. As shown in Fig. 4b 
1-(1H-indol-3-yl)-propane-1,2,3-triol has λmax at 227 and 
279 nm, which is very common among different deriva-
tives of indoles which are reported for having promising 
antitumor activity against several different tumor cell 
lines [34].
Conclusion
From this research work we were successful in isolating 
two potent antitumor compounds from Streptomyces 
KML-2 strain. From the results we can inferred that the 
strain Streptomyces KML-2 is potent source of antitu-
mor agents. This study also reveals that Khewra salt mine 
from where the strain KML-2 was isolated is a potent 
ecological niche with having inimitable strain diversity 
which are yet to be discovered. In short these unique 
habitats should be continuously explored for extracting 
lead antitumor compound. Furthermore we will try to 
check the activity of isolated compounds against different 
cancers including colorectal and liver cancers, which are 




Soil samples were collected from Khewra salt mines, 
Punjab, Pakistan, in sterile sampling bag, from the depth 
Fig. 3 Activity of Compound 1 (a) and Compound 2 (b) against Hela and MCF-7 cell lines
Page 6 of 10Aftab et al. Biol Res  (2015) 48:58 
of 5–10  cm, quantity of each of the collected sample 
was between 2 and 5  g. The samples were then treated 
using different physical and chemical methods for the 
enrichment of actinomycetes. In physical treatment 
the samples were kept at high temperature (55  °C) for 
2–3  weeks and in chemical treatment soil samples were 
Fig. 4 a, b Mass and UV spectra of compounds 1 and 2
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mixed with CaCO3 at the ratio of 10:1 and were incubated 
under moisture rich conditions for 7 days at room temper-
ature [35].
Selective isolation of actinomycetes
Actinomycetes strains were isolated using selective iso-
lation media Glycerol-Casein-KNO3 agar (glycerol 10 g, 
KNO3 2 g, casein 0.3 g, NaCl 2 g, K2HPO4 2 g, MgSO4-
7H2O 0.05  g, CaCO3 0.02  g, FeSO4-7H2O 0.01  g, agar 
18  g, all in 1  l) containing cycloheximide (50 μg/ml) as 
antifungal agent [36]. About 1 g of soil was dissolved in 
autoclaved distilled water and serial dilutions (10−2 to 
10−4) were plated on Glycerol-Casein-KNO3 agar. The 
plates were incubated for 7–21 days at 28 °C. The actino-
mycetes colonies were selected and purified by repeated 
sub-culturing on GYM agar (10 g malt extract, 5 g yeast 
extract, 5 g glucose, 15 g agar, all in 1 l of tap water) [37]. 
Later the selected isolates were preserved in liquid nitro-
gen for future use.
Morphological, biochemical and physiological 
characterization of the isolated strain
The morphologic, biochemical and physiological char-
acteristics of the isolate KML-2 were studied by the 
methods employed in International Streptomyces Project 
(ISP), including colony size, consistency, shape, eleva-
tion, margins, color of aerial/substrate mycelium, pig-
ments diffusing into the medium, formation of melanin, 
utilization of different sugars as sole source of carbon, 
utilization of organic acids, hemolysis, utilization of oxa-
lates, optimum pH, temperature, aeration, media com-
position [37, 38].
Scanning electron microscopy (SEM)
In order to see the deep morphological pattern (substrate 
& aerial mycelia) of strain KLM-2, scanning electron 
microscopy was performed [39]. The strain was grown 
on GYM agar and a piece of agar containing sufficient 
growth of the strain was cut with sterile scalpel. The 
strain was fixed with glutaraldehyde (2  %) and formal-
dehyde (5  %), and then incubated at 4  °C for overnight 
in 0.1  M sodium cacodylate buffer (0.1  M cacodylate, 
0.01  M CaCl2, 0.01  M MgCl2, 0.09  M sucrose; pH 6.9). 
After overnight fixation, the strain was washed with 
fresh cacodylate buffer. The strain was then dehydrated 
with a series of acetone solutions (10, 30, 50, 70, 90, and 
100 % acetone). After acetone dehydration, the agar piece 
containing growth was subjected to critical-point dry-
ing with liquid CO2. Before loading the agar piece in the 
scanning electron microscope (SEM) it was covered with 
Fig. 5 a, b Molecular Structure of Chromomycin SA (Compound 1) and 1-(1H-indol-3-yl) propane- 1, 2, 3-triol (Compound 2)
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a 10  nm thick gold film by sputter coating (Hummer-V 
Sputter Coater). After coating, deep morphological pat-
terns of the substrate mycelia of strain KML-2 were ana-
lyzed by using scanning electron microscope (HITACHI 
S-2300 SEM at Electron microscopy facility, Queens Uni-
versity, Canada).
16S rRNA gene sequencing
Total genomic DNA was isolated after growing the stain 
in GYM broth. Genomic DNA was extracted by the phe-
nol/chloroform method as described by Hopwood et al. 
[40]. The 1.5  kb 16S rDNA fragment was amplified by 
PCR using the universal primers 27F, 5′-AGAGTTT-
GATCCTGGCTCAG-3′ and 1522R, 5′-AAGGAGGT-
GATCCARCCGCA-3′. Each PCR reaction vial contained 
approximately 300 ng genomic DNA, 2 µl of each primer 
having working concentration of 10  pmol, and 25  µl of 
2X PCR master Mix (Merck-GeNei™). The reaction was 
cycled as follows: 94 °C for 5 min; 30 cycles of 94 °C for 
20  s; 50  °C for 20  s; 72  °C for 2  min; followed by 72  °C 
for 5 min. After amplification, the reaction product was 
resolved by agarose gel electrophoresis and gel purified 
using a MiniElute™ PCR purification kit (Qiagen, USA). 
The gene product was sequenced using dye terminator 
chemistry on an automated sequencer (ABI-PRISM® 
BigDye® Terminator version 3.1 Cycle Sequencing 
Kit, Applied Biosystems, USA), and the sequence data 
was compared to existing sequences by BLAST analy-
sis (http://www.nih.nlm.gov/blast.cgi). After analyzing 
BLAST results, phylogenetic and molecular evolutionary 
analysis were conducted using software MEGA (version 
4) [41]. The sequence was then deposited to the NCBI 
GenBank.
Small scale cultivation of strain KML‑2
The Streptomyces strain KML-2 was grown in 250  ml 
GYM broth in 1 l Erlenmeyer flasks (the pH was adjusted 
to 7.8 before sterilization). The flasks were then incubated 
at 28  °C at 100  rpm for 5–7  days. After incubation the 
cells were disrupted by sonication. The resulting broth 
was mixed with ethyl acetate 1:1. The mixture was soni-
cated again and the upper organic layer of ethyl acetate 
was collected in a separatory funnel. The organic layer 
was evaporated on rotary vacuum evaporator (Heidolph® 
4000 efficient) and a small amount of crude extract was 
obtained. The crude extract was analyzed for cytotoxic 
and antitumor activities against different cell lines.
Determination of cytotoxic and antibacterial activity 
of Streptomyces sp. KML‑2
A microwell cytotoxicity assay as described by Solis 
et  al. [42] was used to check the cytotoxicity of the 
crude extract against brine shrimp larvae (Artemia s.). In 
order to calculate the mortality of the larvae, dried eggs 
of Artemia s. (0.5 g) were added to a 500 ml separating 
funnel filled with 400  ml of artificial seawater and were 
incubated at room temperature for 48 h under extensive 
aeration. After incubation the whole suspension was kept 
undisturbed for 1  h in order to allow the eggs to settle 
down. Active larvae were collected by exposing one side 
of the extraction funnel with light source. About 30–40 
active larvae were transferred to the wells of microtiter 
plate (wells diameter 1.8  cm, depth 2  cm) already filled 
with 0.2 ml of salt water. Dead larvae were counted (value 
N) before adding 20  µg of the crude extract in 5  µl of 
DMSO. The plate was kept at room temperature in the 
dark. After 24 h, the number of the dead larvae (value A) 
in each well was counted under the microscope. In order 
to calculate total number of larvae (value G) all of surviv-
ing larvae were killed by the addition of 0.5 ml methanol. 
The test was performed in triplicate; each test row was 
accompanied by a blind sample containing pure DMSO 
as negative control. Actinomycin-D (10 µg/ml) was used 
as a positive control with 100 % mortality rate. Mortality 
rate was calculated by using the following formula:
where, M  =  Percent of the dead larvae after 24  h, 
A = Number of the dead larvae after 24 h, B = Average 
number of the dead larvae in the blind samples after 24 h, 
N  =  Number of the dead larvae before starting of the 
test, G = Total number of larvae.
Antimicrobial activity of the extract obtained from the 
culture broth of Streptomyces sp. KML-2 was determined 
by disc diffusion method as described by Sajid et al. [43] 
against a set of test organisms including Bacillus subti-
lus, E. coli (ATCC 25922), Staphylococcus aureus (ATCC 
25923), Methicilin resistant Staphylococcus aureus 
(MRSA), Acinetobacter, Pseudomonas aeruginosa and 
klebsiella pneumonia (ATCC 706003).
In‑vitro screening for antitumor activity
The antitumor assay was performed on Hela, MDBK, 
Vero and MCF-7 cell lines (ATCC) using MTT assay 
[44]. The cells were grown in 96 well plate in Dulbecco’s 
modified Eagle’s medium (Invitrogen, NY, USA) supple-
mented with 10  % fetal bovine serum and 1  % antibiot-
ics (streptomycin and penicillin-G) by incubating at 37 °C 
for 24 h in 5 % CO2 (Sanyo CO2 incubator MCO-15AC) 
under humid conditions. After the formation of conflu-
ent monolayer of the actively dividing cells, trypsiniza-
tion was done and cell suspension (105 cells/ml) was then 
seeded in the wells containing culture media and differ-
ent concentrations of the extract obtained from the shak-
ing culture of KML-2 strain. Plate was then incubated at 
37 °C for 48 h in 5 % CO2 environment. After incubation 
M = [(A − B − N)/(G− N)] × 100
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cellular viability for each concentration of the extract 
was measured as described by Mosmann, where in 20 µl 
of MTT (5 mg/ml) was added to each well and the plate 
was again incubated at 37 °C for 3 h in 5 % CO2 environ-
ment. After incubation the media was carefully removed 
and 100  µl of DMSO was added in order to solubilize 
the formazan crystals produced by metabolically active 
cells. The optical density (O.D) of the wells were then 
measured with a microplate reader (Epoch BIOTEK®) 
at 570  nm with 655  nm as reference  wavelength. Cel-
lular images were taken through inverted microscope 
(LABOMED iVu3000-TCM400). Assay controls were 
maintained throughout the experiment and the assay 
was performed in triplicates. Calculations of IC50 were 
done through dose dependent curve. The growth inhibi-
tion rate for each dilution was calculated by the following 
formula:
Fermentation and extraction
A starter culture was prepared by inoculating 25 ml GYM 
broth with the strain KML-2 and incubating at 28  °C 
for 4 days at 95  rpm. Fermentation was done in ten 5  l 
EM baffled flasks containing springs and glass beads. 
Each flask contained 2  l GYM broth for a total working 
volume of 20  l. Antifoaming agent 204 (Sigma Aldrich), 
100 µl/l, and 2 % (v/v) inoculum was added to each flask. 
The cultures were incubated at 28 °C for 7 days at 95 rpm. 
After 7 days the culture broth was harvested by centrifu-
gation at 11,000 rpm for 5 min at ambient temperature. 
After centrifugation, the liquid phase was separated and 
Diaion® HP-20 beads (Sapelca analytical USA), pre-
washed three times with acetone and air dried overnight, 
were added at a ratio of 10  g/l. This mixture was incu-
bated for 3 h on a rotary shaker at 100 rpm, and then sep-
arated by vacuum filtration. The beads were washed with 
water 2–3 times followed by three times  washing with 
acetone. The acetone was removed under vacuum to dry-
ness. The solid phase or cellular mass was also extracted 
three times with ethyl acetate and the solvent was evapo-
rated under vacuum to dryness.
Purification and structure elucidation by UPLC–MS 
and NMR analysis
The combined crude extract (extract from liquid as well 
as solid phase) was fractionated on silica gel column 
(25 × 5 cm, Silica gel 60, Merck). The fractions were puri-
fied by repeated silica gel column chromatography and 
preparative TLC (PTLC) with a mobile phase of CH2Cl2/
MeOH gradient. Final finishing of the purified compounds 
Inhibition rate
=
O.D (control well) − O.D (treated well)
O.D (control well)
× 100
was done by passing the fractions through Sephadex 
LH-20 column. The structures of the purified compounds 
were analyzed through UPLC-mass spectrometry and 
NMR spectroscopy. The data obtained was compared 
with reference data present in databases including: Dic-
tionary of Natural Products (DNP), Pub Chem, Scifinder 
and Chemical abstracts. Compound 1 and 2 were isolated 
and characterized by UPLC-MS and NMR spectroscopy. 
For UPLC-MS analysis samples were prepared carefully 
by dissolving the powder compound in 500 µl methanol. 
Furthermore this methanolic compound mixture was five 
times diluted in 50 % acetonitrile. The diluted samples were 
then filtered through 2  µm pore size disposable syringe 
filters and further centrifuged at 14,000  rpm in order to 
remove any particle. Samples were then transferred to spe-
cial LC–MS glass vials which were further placed in the 
sample tray of UPLC-MS machine. The analytical condi-
tions for the UPLC-MS analysis were as follows: Waters 
ACQUITY UPLC H-class BEH-C18, (2.1  ×  100  mm; 
particle size, 1.7  μm) column; Column temperature: 
Ambient; Gradient Elution: A is Acetonitrile, B is Acetoni-
trile + 0.5 % acetic acid, C is MilliQ water + 0.5 % acetic 
acid, D is MilliQ water; Gradient Profile: 0–1.5 min 5 % B 
and 95 % C, 1.5–7 min is 95 % B and 5 % C, 7–10 min 95 % 
B and 5 % C, Before and after run column was re-equili-
brate by eluting with 100 % A and B; Flow rate: 0.5 ml/min; 
m/z monitoring range 200–2000  m/z ratio; Wavelength 
monitoring range 220–800  nm; Total run time: 10  min; 
Data: Continuum; Seal wash period: 5  min; Waters SQ 
detector mass spectrometer; Ionization mode: ESI posi-
tive; Scan Duration: 0.5 s; Capillary voltage, 3.3 kV; Cone 
voltage ramp: on; Source temperature: 150 °C; Desolvation 
temperature: 400  °C; Desolvation gas flow: 800  l/h; Cone 
voltage; 0  V; Desolvation gas: liquid nitrogen; Mass lynx 
software V 4.1 (waters).
Structure of the compounds were elucidate on Bruker 
Avance 600  MHz NMR machine by using simple 1D 
and 2D NMR spectroscopic techniques for 1H- and 13C. 
Several techniques including COSY, HMBC, HSQC and 
NOESY were also performed for the correct structure 
elucidation in the 2D NMR spectroscopic analysis.
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